AVBPArriVent BioPharma, Inc.

$21.02+7.1% 1Y

Is the price fair?

What AVBP's price assumes

Price / book
4.51

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
4.51
Market capitalisation49.3 million shares, counted Aug 10, 2026
$1.04B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks